Most recent by Lawrence F. Eichenfield, MD
VIDEO: Maui Derm case presentations highlight both traditional, changing psoriasis care
In this exclusive video, Lawrence F. Eichenfield, MD, a member of the Healio Dermatology Peer Perspective Board, discusses psoriasis case reports presented at Maui Derm 2025.
VIDEO: Unmet needs in psoriasis care
In this Healio exclusive video, Lawrence F. Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego, discusses areas of unmet need in the field of psoriasis.
VIDEO: Oral therapies in pediatric, adolescent psoriasis
In this Healio exclusive video, Lawrence F. Eichenfield, MD, discusses oral treatments available to pediatric and adolescent psoriasis discussed at Maui Derm 2025.
VIDEO: Incorporating new topical treatments into pediatric, adolescent psoriasis care
In this Healio exclusive video, Lawrence F. Eichenfield, MD, talks about takeaways in updates on topical treatments for pediatric and adolescent psoriasis discussed at Maui Derm 2025.
FDA approves Ycanth as first molluscum contagiosum treatment
The FDA has approved Ycanth topical solution for the treatment of the viral skin infection molluscum contagiosum in patients aged as young as 2 years, Verrica Pharmaceuticals announced in a press release.
Abrocitinib demonstrates rapid efficacy in treating atopic dermatitis
A 200 mg dose of abrocitinib met stringent efficacy endpoints among substantial portions of patients with moderate to severe atopic dermatitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Evolving perspectives on pathogenesis, management of AD
There has been a tremendous evolution in our understanding of atopic dermatitis in the past few years.